Streetbeat News

Equity Actions

SBUX

Whales have shown a bullish stance on Starbucks (NASDAQ:SBUX) with significant options activity. 47% of trades were bullish and 47% bearish, with a notable amount of calls ($6.39M) compared to puts ($147.5K). Analysts have set a price target around $84.5, with current stock price at $79.5.

Portfolio Pulse from Benzinga Insights

May 31, 2024 | 3:01 pm

NKLA

Nikola Corporation (NASDAQ:NKLA) shares are trading higher on Friday after hitting a new all-time low of 49 cents earlier in the week. The company is on the preliminary list for deletion from the Russell 3000 index, pending a vote on a reverse stock split to address potential delisting concerns.

Portfolio Pulse from Erica Kollmann

May 31, 2024 | 2:30 pm

VEON

VEON Ltd. (NASDAQ:VEON) held its Annual General Meeting where shareholders approved a new Board of Directors. The new Board includes former U.S. Secretary of State Michael R. Pompeo and elected Augie K Fabela II as Chairman.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2024 | 2:12 pm

PSHZF

Bill Ackman is planning an IPO for his investment firm, Pershing Square Capital Management. Additionally, Pershing Square is concluding a $1 billion funding round with institutional investors and family offices.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2024 | 1:58 pm

DBVT

DBV Technologies has announced a change in the ratio of its American Depositary Shares (ADS) to its ordinary shares. The new ratio will be 1 ADS to 1 ordinary share, effective around June 7th, 2024.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2024 | 1:53 pm

PAYC

Paycom Software announced that Christopher G. Thomas has resigned from his position as Co-CEO for personal reasons, effective immediately. Chad Richison will continue to lead the company as CEO, President, and Chairman of the Board.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2024 | 1:22 pm

LPTV

Loop Media has announced a registered direct offering of $2.45 million, involving 9.65 million shares of common stock priced at $0.15 per share.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2024 | 1:19 pm

NVOS

Novo Integrated Sciences shares are trading higher following the company's approval of a $5 million stock repurchase. The board is also reviewing the possibility of increasing the repurchase amount.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2024 | 1:08 pm

NVOS

Novo Integrated Sciences has approved a $5 million stock repurchase program for open market and private transactions.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2024 | 1:01 pm

CLDI

Calidi Biotherapeutics has announced an agreement to immediately exercise 10.7 million warrants, reducing the exercise price to $0.20. This exercise is expected to generate approximately $2.1 million in gross proceeds.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2024 | 12:55 pm